Stock Events

Stock Events

THC Therapeutics 

$0.000700
5
+$0.00+75%Wednesday 15:37

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.02
52W Low
0.0001
Volume
227,611
Avg. Volume
265
Mkt Cap
28,186.2
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Dec 22Expected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q3 2022
-0.09
-0.05
-0.02
0.02
Expected EPS
N/A
Actual EPS
-0.0649

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-812,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.19B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap533.49M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, posing competition in both medicinal and recreational cannabis sectors.
Canopy Growth
CGC
Mkt Cap370.33M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with THC Therapeutics in various cannabis markets.
Aurora Cannabis
ACB
Mkt Cap248.18M
Aurora Cannabis is engaged in the production and distribution of medical cannabis, competing in the same space as THC Therapeutics.
Green Thumb Industries
GTBIF
Mkt Cap1.56B
Green Thumb Industries Inc. engages in the manufacture and distribution of cannabis products, competing in the same market as THC Therapeutics.

About

THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves. Established in 2007, the organization was initially known as Millennium Blockchain, Inc. before officially changing its name to THC Therapeutics, Inc. in September 2018. The company's corporate headquarters are located in Las Vegas, Nevada.
Show More
CEO
Scott A. Cox
Employees
1
Country
United States
ISIN
US87248Q1013

Listings

OTC Link
US
THCT

0 Comments

Share your thoughts

FAQs

What is THC Therapeutics stock price today?▼
The current price of THCT is $0.00 USD — it has increased by +75% in the past 24 hours. Watch THC Therapeutics stock price performance more closely on the chart.
What is THC Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange THC Therapeutics stocks are traded under the ticker THCT.
Is THC Therapeutics stock price growing?▼
THCT stock has risen by +75% compared to the previous week, the month change is a +133.33% rise, over the last year THC Therapeutics has showed a +600% increase.
What is THC Therapeutics market cap?▼
Today THC Therapeutics has the market capitalization of 28,186.2
What were THC Therapeutics earnings last quarter?▼
THCT earnings for the last quarter are -0.06 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is THC Therapeutics revenue for the last year?▼
THC Therapeutics revenue for the last year amounts to 0 USD.
What is THC Therapeutics net income for the last year?▼
THCT net income for the last year is -812,000 USD.
How many employees does THC Therapeutics have?▼
As of November 1, 2026, the company has 1 employees.
In which sector is THC Therapeutics located?▼
THC Therapeutics operates in the Health & Wellness sector.
When did THC Therapeutics complete a stock split?▼
The last stock split for THC Therapeutics was on December 10, 2018 with a ratio of 1:10.
Where is THC Therapeutics headquartered?▼
THC Therapeutics is headquartered in Jacksboro, United States.